217 related articles for article (PubMed ID: 28635330)
1. Multiple functions of insulin-degrading enzyme: a metabolic crosslight?
Tundo GR; Sbardella D; Ciaccio C; Grasso G; Gioia M; Coletta A; Polticelli F; Di Pierro D; Milardi D; Van Endert P; Marini S; Coletta M
Crit Rev Biochem Mol Biol; 2017 Oct; 52(5):554-582. PubMed ID: 28635330
[TBL] [Abstract][Full Text] [Related]
2. Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.
Tang WJ
Trends Endocrinol Metab; 2016 Jan; 27(1):24-34. PubMed ID: 26651592
[TBL] [Abstract][Full Text] [Related]
3. Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease.
Fernández-Gamba A; Leal MC; Morelli L; Castaño EM
Curr Pharm Des; 2009; 15(31):3644-55. PubMed ID: 19925417
[TBL] [Abstract][Full Text] [Related]
4. Insulin-degrading enzyme: a link between Alzheimer's and type 2 diabetes mellitus.
Haque R; Nazir A
CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):259-64. PubMed ID: 24059320
[TBL] [Abstract][Full Text] [Related]
5. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
[TBL] [Abstract][Full Text] [Related]
6. Insulin-degrading enzyme: an ally against metabolic and neurodegenerative diseases.
Sousa L; Guarda M; Meneses MJ; Macedo MP; Vicente Miranda H
J Pathol; 2021 Dec; 255(4):346-361. PubMed ID: 34396529
[TBL] [Abstract][Full Text] [Related]
7. Enzyme kinetics from circular dichroism of insulin reveals mechanistic insights into the regulation of insulin-degrading enzyme.
Ivancic VA; Krasinski CA; Zheng Q; Meservier RJ; Spratt DE; Lazo ND
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30305381
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
Cordes CM; Bennett RG; Siford GL; Hamel FG
Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
[TBL] [Abstract][Full Text] [Related]
9. Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease?
Pivovarova O; Höhn A; Grune T; Pfeiffer AF; Rudovich N
Ann Med; 2016 Dec; 48(8):614-624. PubMed ID: 27320287
[TBL] [Abstract][Full Text] [Related]
10. Degradation of amylin by insulin-degrading enzyme.
Bennett RG; Duckworth WC; Hamel FG
J Biol Chem; 2000 Nov; 275(47):36621-5. PubMed ID: 10973971
[TBL] [Abstract][Full Text] [Related]
11. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
[TBL] [Abstract][Full Text] [Related]
12. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.
Qiu WQ; Folstein MF
Neurobiol Aging; 2006 Feb; 27(2):190-8. PubMed ID: 16399206
[TBL] [Abstract][Full Text] [Related]
13. Insulin-degrading enzyme (IDE): a novel heat shock-like protein.
Tundo GR; Sbardella D; Ciaccio C; Bianculli A; Orlandi A; Desimio MG; Arcuri G; Coletta M; Marini S
J Biol Chem; 2013 Jan; 288(4):2281-9. PubMed ID: 23188819
[TBL] [Abstract][Full Text] [Related]
14. The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design.
Tundo GR; Grasso G; Persico M; Tkachuk O; Bellia F; Bocedi A; Marini S; Parravano M; Graziani G; Fattorusso C; Sbardella D
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892174
[TBL] [Abstract][Full Text] [Related]
15. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-Analysis.
Zhang H; Liu D; Huang H; Zhao Y; Zhou H
Curr Alzheimer Res; 2018; 15(7):610-617. PubMed ID: 29357797
[TBL] [Abstract][Full Text] [Related]
17. A neglected modulator of insulin-degrading enzyme activity and conformation: The pH.
Grasso G; Satriano C; Milardi D
Biophys Chem; 2015; 203-204():33-40. PubMed ID: 26025789
[TBL] [Abstract][Full Text] [Related]
18. Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides.
Kurochkin IV; Guarnera E; Wong JH; Eisenhaber F; Berezovsky IN
Biochemistry; 2017 Jan; 56(1):228-239. PubMed ID: 27982586
[TBL] [Abstract][Full Text] [Related]
19. New Insights on the Regulation of the Insulin-Degrading Enzyme: Role of microRNAs and RBPs.
Martín-Martín Y; Pérez-García A; Torrecilla-Parra M; Fernández-de Frutos M; Pardo-Marqués V; Casarejos MJ; Busto R; Ramírez CM
Cells; 2022 Aug; 11(16):. PubMed ID: 36010613
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein.
Farris W; Leissring MA; Hemming ML; Chang AY; Selkoe DJ
Biochemistry; 2005 May; 44(17):6513-25. PubMed ID: 15850385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]